1. Home
  2. XENE vs PFSI Comparison

XENE vs PFSI Comparison

Compare XENE & PFSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

XENE

Xenon Pharmaceuticals Inc.

HOLD

Current Price

$55.81

Market Cap

5.2B

Sector

Health Care

ML Signal

HOLD

PFSI

PennyMac Financial Services Inc.

HOLD

Current Price

$83.46

Market Cap

4.3B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
XENE
PFSI
Founded
1996
2008
Country
Canada
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Finance: Consumer Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
5.2B
4.3B
IPO Year
2014
2018

Fundamental Metrics

Financial Performance
Metric
XENE
PFSI
Price
$55.81
$83.46
Analyst Decision
Strong Buy
Buy
Analyst Count
11
9
Target Price
$68.55
$128.11
AVG Volume (30 Days)
1.5M
491.2K
Earning Date
05-08-2026
05-05-2026
Dividend Yield
N/A
1.35%
EPS Growth
N/A
59.25
EPS
N/A
1.53
Revenue
$311,000.00
$984,629,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$2,496.48
$16.96
P/E Ratio
N/A
$52.44
Revenue Growth
N/A
3.05
52 Week Low
$30.00
$77.67
52 Week High
$62.91
$160.36

Technical Indicators

Market Signals
Indicator
XENE
PFSI
Relative Strength Index (RSI) 60.01 50.20
Support Level $52.40 $77.67
Resistance Level $56.66 $88.65
Average True Range (ATR) 1.72 2.55
MACD 0.46 0.29
Stochastic Oscillator 86.26 70.83

Price Performance

Historical Comparison
XENE
PFSI

About XENE Xenon Pharmaceuticals Inc.

Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.

About PFSI PennyMac Financial Services Inc.

PennyMac Financial Services Inc is a specialty financial services firm with a comprehensive mortgage platform mainly focused on the production and servicing of U.S. residential mortgage loans. The firm is also engaged in managing investments related to the U.S. mortgage market and provides products and services that leverage technologies to support customers. The company operates through two reportable operating segments: production and servicing. The production segment performs loan origination, acquisition, and sale activities, while the servicing segment performs servicing and subservicing of loans, early buyout transactions, and servicing of loans sourced and managed for PMT. The majority of revenue comes from the production segment.

Share on Social Networks: